POTTS JOHN T JR 4
4 · BIOSANTE PHARMACEUTICALS INC · Filed Mar 30, 2012
Insider Transaction Report
Form 4
POTTS JOHN T JR
Director
Transactions
- Award
Non-Statutory Stock Option (right to buy)
2012-03-30+25,000→ 25,000 totalExercise: $0.68From: 2013-03-30Exp: 2022-03-29→ Common Stock (25,000 underlying)
Holdings
- 2,657
Common Stock
- 2,924(indirect: By Trust)
Common Stock